Comparison of Allen Carr's Easyway programme with a specialist behavioural and pharmacological smoking cessation support service: a randomized controlled trial.

ABSTRACT:

Background and aims

A combination of behavioural and pharmacological support is judged to be the optimal approach for assisting smoking cessation. Allen Carr's Easyway (ACE) is a single-session pharmacotherapy-free programme that has been in operation internationally for 38 years. We compared the effectiveness of ACE with specialist behavioural and pharmacological support delivered to the national standard in England.

Design

A two-arm, parallel-group, single-blind, randomized controlled trial.

Setting

London, UK, between February 2017 and May 2018.

Participants

A total of 620 participants (310 in ACE and 310 in the combined behavioural and pharmacological support condition) were included in the analysis. Adult (≥ 18 years) smokers wanting to quit were randomize

SUBMITTER: Frings D 

PROVIDER: S-EPMC7186816 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature